Literature DB >> 22942802

Perceptions of Health and Relationships to Disability Measures among People with Multiple Sclerosis.

Heather Becker1, Alexa Stuifbergen.   

Abstract

Researchers use various measures to assess health status, impairment, functional limitations, and disability among people with Multiple Sclerosis. However, conceptually and empirically relationships among measures are not always clear. The purpose of this study was to examine the relationships among measures of impairment, disability, functional status and health related outcomes within a sample of 443 individuals with MS. A secondary purpose was to compare the reported health status of this sample to the health status of a population-based sample of individuals with and without disabilities. While both the MS sample and a population-based sample of individuals with activities limitations indicated poorer health than did their non-disabled counterparts, the MS sample reported more days in the past month when physical and mental health was not good and more days when poor health kept them from usual activities than the population-based sample of individuals with disabilities. Most measures were moderately intercorrelated, but the pattern suggests that issues such as the time period specified may affect the relationships. Researchers are advised to carefully consider operational as well as conceptual definitions, length of proposed measures, and appropriate time frame, as well as more traditional criteria of reliability and validity when selecting study measures.

Entities:  

Year:  2009        PMID: 22942802      PMCID: PMC3430520          DOI: 10.7224/1537-2073-11.2.57

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  15 in total

1.  Revised estimate of the prevalence of multiple sclerosis in the United States.

Authors:  D W Anderson; J H Ellenberg; C M Leventhal; S C Reingold; M Rodriguez; D H Silberberg
Journal:  Ann Neurol       Date:  1992-03       Impact factor: 10.422

2.  Psychometric assessment of the Quality of Life Index.

Authors:  C E Ferrans; M J Powers
Journal:  Res Nurs Health       Date:  1992-02       Impact factor: 2.228

3.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

5.  Can comorbidity be measured by questionnaire rather than medical record review?

Authors:  J N Katz; L C Chang; O Sangha; A H Fossel; D W Bates
Journal:  Med Care       Date:  1996-01       Impact factor: 2.983

6.  The disablement process.

Authors:  L M Verbrugge; A M Jette
Journal:  Soc Sci Med       Date:  1994-01       Impact factor: 4.634

7.  Measuring disability with parsimony.

Authors:  L M Verbrugge; S S Merrill; X Liu
Journal:  Disabil Rehabil       Date:  1999 May-Jun       Impact factor: 3.033

8.  Enabling our instruments: accommodation, universal design, and access to participation in research.

Authors:  A R Meyers; E M Andresen
Journal:  Arch Phys Med Rehabil       Date:  2000-12       Impact factor: 3.966

9.  Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale).

Authors:  E M Andresen; J A Malmgren; W B Carter; D L Patrick
Journal:  Am J Prev Med       Date:  1994 Mar-Apr       Impact factor: 5.043

10.  Does the relationship between physical activity and quality of life differ based on generic versus disease-targeted instruments?

Authors:  Robert W Motl; Edward McAuley; Erin M Snook; Rachael C Gliottoni
Journal:  Ann Behav Med       Date:  2008-08-22
View more
  1 in total

1.  Severity of chronic Lyme disease compared to other chronic conditions: a quality of life survey.

Authors:  Lorraine Johnson; Spencer Wilcox; Jennifer Mankoff; Raphael B Stricker
Journal:  PeerJ       Date:  2014-03-27       Impact factor: 2.984

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.